Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Centers for Medicare & Medicaid Services finalized a host of actions ranging from broker compensation, health equity, mental health, supplemental benefits and biosimiliars, in the Contract Year 2025 Medicare Advantage and Part D final rule Thursday night.
Total gross Medicare spending on GLP-1 drugs has skyrocketed, rising from $57 million in 2018 to $5.7 billion in 2022.
President Joe Biden is widening a critical window for low-income Americans to join Obamacare, in a move aimed at reinforcing a central element of his reelection bid: That he presided over a historic expansion of health care coverage.
Kaiser Permanente and a pair of investment firms have unveiled a joint venture to help older, low-income adults receive care support without needing to be moved from their homes.
This year US health insurers have to navigate strong crosscurrents from demographic shifts, regulatory changes, and member preferences. How they react now can have an impact for years to come.
The Biden administration on Monday followed through on its proposal to cut next year’s base payments to Medicare Advantage plans an average of 0.16%, despite pressure from insurers and their allies in Congress. Why it matters: While the plans will wind up seeing a net increase once payments are risk-adjusted to account for the health of their customers, ...
Some Medicare prescription plans will start paying for weight-loss medications for people with heart disease.
As expected, insurance-friendly groups are upset over the feds’ MA benchmark payment decision Monday. Global strategy firm Capstone said the CMS decision most negatively impacts Humana, UnitedHealth Group, Elevance Health, Cigna and certain providers like Agilon that were expecting high utilization rates last quarter to be represented in the growth rate, which decreased compared to ...
Many hospitals are adding billions of dollars in fees for routine care in outpatient centers they own, raising patient costs for colonoscopies, mammograms and heart screenings, a new investigation found.
Medicare will provide coverage for Wegovy for patients with an increased risk of heart attack, stroke or other serious cardiovascular problems, an agency spokesperson said Thursday.